We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.50
Change: 1.00 (0.91%)
Spread: 1.00 (0.913%)
Open: 110.00
High: 112.00
Low: 109.50
Prev. Close: 109.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amended Financing Agreement

29 Sep 2022 11:51

RNS Number : 1923B
McBride PLC
29 September 2022
 

29 September 2022

 

McBride plc

 

Amended Financing Agreement

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today announces the agreement of amendments to the Group's financing agreements.

In summary, the Group's €175m sustainability-linked revolving credit facility (RCF) remains in place to its original maturity date of May 2026. However, there will be no covenant tests until September 2024, other than a liquidity limit which has been reduced to £15m from the £40m in place since our first covenant waiver in December 2021. As part of this arrangement, the lender group has been granted a security package over assets and investments and there is a modest and progressive step down in the RCF commitment from September 2024. Additionally, the invoice discounting lines, totalling £83m, have been extended and committed to September 2024. More detail on these amendments is set out below.

These financing agreements provide a firm funding platform permitting the Group to further progress its Compass ambitions, as outlined in February 2021. The Group would like to express its thanks for the support that the lender group has given to the Group both through this recent period of uncertainty and in the amendment of our agreements.

The key provisions of the revised agreement are:

€175m sustainability-linked revolving credit facility

· This is reconfirmed to May 2026 (no change from current agreement)

· The RCF is to be secured against material assets, shares and inter-company balances, subject to a mutual agreement to review the continuing requirement for security once the Group is in compliance with the financial covenants below

· Commitments to reduce (and be cancelled) in the amount of the euro equivalent of £2.5m every three months from September 2024 up until the maturity date.

Existing bilateral overdraft facilities with the lender group

· Overdrafts of £5m and €15m shall become ancillary facilities under the RCF, committed until 30 September 2024

Invoice discounting facilities

· Committed to 30 September 2024

Covenants:

· Liquidity

shall not be less than £15m on or prior to 30 September 2024

shall not be less than £25m post 30 September 2024

· Net debt cover

to be tested quarterly from 30 September 2024

shall not exceed 3:1 for 30 September 2024 and 31 December 2024

shall not exceed 2.75:1 thereafter

· Interest cover

to be tested quarterly from 30 September 2024

to be no less than 3.4:1 for 30 September 2024

to be no less than 3.9:1 for 31 December 2024

to be no less than 4:1 for 31 March 2025 and 30 June 2025

to be no less than 4.25:1 thereafter

· No dividends will be paid to shareholders until the RCF is refinanced (at maturity or earlier)

Pricing and fees:

· No increase in margin applicable to borrowings when debt cover 2.5x or lower

· When debt cover 2.5x or higher, margin applicable to borrowings rises by 35-235 bps depending on debt cover level

· The arrangement includes an 'upside sharing' mechanism whereby, subject to certain exceptions, a fee will become payable by the Group to members of the lending group upon the occurrence of an exit event (e.g., change of control of the Group or a prepayment or repayment in full of the facility). The fee will equate to 11% of any increase from the current market capitalisation of the Group to the market capitalisation of the Group at the date of the exit event (subject to deductions for any increase to market capitalisation relating to certain share issues).

The Group considers that the arrangement achieves an appropriate balance between the interests of all stakeholders of the Group. In particular, we have been in regular discussion and consultation with the Trustee of the Group's defined benefit pension scheme in the UK. In order to preserve and support the position of the scheme, with the support of the lender group, we have agreed to provide in favour of the scheme a package of additional credit support in the UK, as well as a new information sharing protocol to ensure ongoing communication between the Group and the Trustee remains comprehensive.

 

Commenting, Mark Strickland, CFO, said:

"This reset of our financing agreements is the culmination of detailed reviews of the business prospects by the Board, its financial advisors and the lender group, and is an excellent outcome following the very difficult trading period over the past 12 to 18 months. It provides the business with funding certainty as our trading prospects recover and we refocus our teams on the improvements anticipated through the Compass strategies."

 

For further information, please contact:

McBride plc

 

Chris Smith, Chief Executive Officer

0161 203 7570

Mark Strickland, Chief Financial Officer

0161 203 7570

FTI Consulting LLP

020 3727 1017

Ed Bridges, Nick Hasell

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUUABUPPGUB
Date   Source Headline
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.